Purple Biotech Ltd.
NASDAQ:PPBT
Overview | Financials
Company Name | Purple Biotech Ltd. |
Symbol | PPBT |
Currency | USD |
Price | 2.97 |
Market Cap | 5,721,589 |
Dividend Yield | 0% |
52-week-range | 2.87 - 25.8 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Isaac Israel |
Website | https://purple-biotech.com |
An error occurred while fetching data.
About Purple Biotech Ltd.
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhibitors, which
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD